WHO ICTRP trial
Comparison of Venlafaxine and Sertraline Therapeutic Effects on Depression in…
IRCT20210608051515N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20210608051515N2 |
|---|---|
| Public title | Comparison of Venlafaxine and Sertraline Therapeutic Effects on Depression in Patients with Epilepsy |
| Scientific title | Evaluation of the Effectiveness of Antidepressant Agents, Venlafaxine Versus Sertraline in Patients with Epilepsy and Depression |
| Primary sponsor | Tehran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Condition 1: Depressive Disorders. Condition 2: Epilepsy. Mood disorder due to known physiological condition with depressive features Epilepsy and recurrent seizures;F06.31 |
| Interventions | Intervention 1: Intervention group 1: venlafaxine; Drug therapy started with 37.5 mg in the first week, reached 75 mg in the second week and finally reached 150 mg in the third week to the sixteenth week. Intervention 2: Intervention group… |
| Registration date | Jul 18, 2021 |
| Target size | 30 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: